Sangamo selects winning bids in Chapter 11 asset auction for USD 163.55 million cash at close
Sangamo loses Nasdaq listing appeal after minimum bid price breach
Sangamo Therapeutics ends Ernst & Young as auditor after Chapter 11 filing